Key CareDx Events Scheduled at American Transplant Congress 2018
June 01 2018 - 8:00AM
CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused
on the discovery, development and commercialization of clinically
differentiated, high-value diagnostic solutions for transplant
patients, will present data highlighting the AlloSure test at the
American Transplant Congress (ATC) taking place from June 2-6, 2018
in Seattle, WA.
“ATC is the primary meeting for the transplant community to
exchange new scientific and clinical information relevant to solid
organ and tissue transplantation. This meeting brings together the
American Society of Transplant Surgeons and the American Society of
Transplantation for a comprehensive attendee base from all centers
across the US,” said Ronald Gill, Ph.D., AST President, Professor
of Surgery and Immunology at the University of Colorado.
CareDx's sponsored Lunch Symposium* entitled, Innovation in
Allograft Health Surveillance: Clinical Implementation of AlloSure
Testing for Kidney Transplant Recipients will be held from 1:00 PM
to 2:15 PM Pacific Time on June 5th, 2018 at the Sheraton Seattle
Hotel. The symposium will detail a center’s implementation of
AlloSure into clinical use as well as case studies from the
following top transplant centers across the United States who have
adopted AlloSure into clinical practice: Allegheny Health Network,
Cedars-Sinai Medical Center, Medical University of South Carolina,
Memorial Hermann Hospital, Saint Barnabus Medical Center, and
University of Colorado.
Additionally, there are four presentations highlighting AlloSure
during the main ATC program (listed in order of presentation
date):
Repeat Kidney Transplant Patients with Active Rejection Have
Elevated Donor-Derived Cell-Free DNA
Shikha Mehta, M.D.
Session: Poster Session A: Kidney Acute Antibody
Mediated Rejection Date: Saturday,
June 2, 2018 Location: Hall 4EF,
Washington State Convention Center
Publication/Poster Board Number: A98
Presentation Time: 5:30 pm – 7:30 pm
Donor-Derived Cell-Free DNA Outperforms Serum Creatinine Changes
for Identifying Kidney Transplant Rejection
Matthew R. Weir, M.D.
Session: Poster Session A: Kidney Acute Antibody
Mediated Rejection Date: Saturday,
June 2, 2018 Location: Hall 4EF,
Washington State Convention Center
Publication/Poster Board Number: A90
Presentation Time: 5:30 pm – 7:30 pm
Donor-Derived Cell-Free DNA Identifies Antibody-Mediated
Rejection with Graft Injury in DSA-Positive Kidney Transplant
Recipients Stanley C.
Jordan, M.D. Session:
Concurrent Session: Kidney Acute Antibody Mediated Rejection
Date: Sunday, June 3, 2018
Time: 2:30 pm – 4:00 pm
Publication Number: 24 Presentation
Time: 3:30 pm
Clinically Relevant Variation of Donor-Derived Cell-Free DNA
during Longitudinal Surveillance of Renal Allografts
Mohanram Narayanan, M.D.
Session: Poster Session D: Kidney: Acute
Cellular Rejection Date: Tuesday,
June 5, 2018 Thanks Location: Hall
4EF, Washington State Convention Center
Publication/Poster Board Number: D194
Presentation Time: 6:00 pm – 7:00 pm
“We look forward to having a major presence at ATC this year.
Since we launched AlloSure in October 2017, we have heard many
compelling examples of AlloSure’s impact on kidney transplant
patients. Our lunch symposium and planned meetings throughout the
week give CareDx the opportunity to share these experiences with
the broader transplant community,” said Peter Maag, Chief Executive
Officer at CareDx, Inc.
Additional information regarding CareDx’s presentations,
symposium, and data can be found at the CareDx booth in the ATC
exhibitor hall (Booth #619).
*This symposium is not part of the ATC official educational
program and the sessions and content are not endorsed by ATC
About CareDx CareDx,
Inc., headquartered in Brisbane, California, is a molecular
diagnostics company focused on the discovery, development and
commercialization of clinically differentiated, high-value
diagnostic solutions for transplant recipients. CareDx offers
products along the pre- and post-transplant testing continuum.
For more information, please visit: www.CareDx.com.
CONTACTS:
CareDx, Inc.Sasha KingChief Commercial Officer+1
415-287-2393sking@caredx.com
Investor RelationsDavid ClairIntegrated Corporate Relations,
Inc.+1 646-277-1266david.clair@icrinc.com
CareDx (NASDAQ:CDNA)
Historical Stock Chart
From Mar 2024 to Apr 2024
CareDx (NASDAQ:CDNA)
Historical Stock Chart
From Apr 2023 to Apr 2024